98 related articles for article (PubMed ID: 22396105)
1. A Herpesvirus saimiri-based vector expressing TRAIL induces cell death in human carcinoma cell lines and multicellular spheroid cultures.
Turrell SJ; Macnab SA; Rose A; Melcher AA; Whitehouse A
Int J Oncol; 2012 Jun; 40(6):2081-9. PubMed ID: 22396105
[TBL] [Abstract][Full Text] [Related]
2. Production of recombinant Herpesvirus saimiri-based vectors.
Whitehouse A
Cold Spring Harb Protoc; 2011 Dec; 2011(12):1515-9. PubMed ID: 22135662
[TBL] [Abstract][Full Text] [Related]
3. Assessment of infectivity using a Herpesvirus saimiri (HVS) recombinant that expresses HVS-GFP.
Whitehouse A
Cold Spring Harb Protoc; 2011 Dec; 2011(12):1520-3. PubMed ID: 22135663
[TBL] [Abstract][Full Text] [Related]
4. Gardella gel analysis to detect Herpesvirus saimiri episomal DNA.
Whitehouse A
Cold Spring Harb Protoc; 2011 Dec; 2011(12):1524-6. PubMed ID: 22135664
[TBL] [Abstract][Full Text] [Related]
5. Efficient infection and persistence of a herpesvirus saimiri-based gene delivery vector into human tumor xenografts and multicellular spheroid cultures.
Smith PG; Burchill SA; Brooke D; Coletta PL; Whitehouse A
Cancer Gene Ther; 2005 Mar; 12(3):248-56. PubMed ID: 15540115
[TBL] [Abstract][Full Text] [Related]
6. Herpesvirus saimiri-based vector biodistribution using noninvasive optical imaging.
Smith PG; Oakley F; Fernandez M; Mann DA; Lemoine NR; Whitehouse A
Gene Ther; 2005 Oct; 12(19):1465-76. PubMed ID: 15889136
[TBL] [Abstract][Full Text] [Related]
7. The herpesvirus saimiri ORF 73 regulatory region provides long-term transgene expression in human carcinoma cell lines.
Giles MS; Smith PG; Coletta PL; Hall KT; Whitehouse A
Cancer Gene Ther; 2003 Jan; 10(1):49-56. PubMed ID: 12489028
[TBL] [Abstract][Full Text] [Related]
8. Herpesvirus saimiri: a potential gene delivery vector (review).
Whitehouse A
Int J Mol Med; 2003 Feb; 11(2):139-48. PubMed ID: 12525867
[TBL] [Abstract][Full Text] [Related]
9. In vivo episomal maintenance of a herpesvirus saimiri-based gene delivery vector.
Smith PG; Coletta PL; Markham AF; Whitehouse A
Gene Ther; 2001 Dec; 8(23):1762-9. PubMed ID: 11803395
[TBL] [Abstract][Full Text] [Related]
10. Development of herpesvirus-based episomally maintained gene delivery vectors.
Calderwood MA; White RE; Whitehouse A
Expert Opin Biol Ther; 2004 Apr; 4(4):493-505. PubMed ID: 15102599
[TBL] [Abstract][Full Text] [Related]
11. Herpesvirus saimiri-based gene delivery vectors.
Griffiths RA; Boyne JR; Whitehouse A
Curr Gene Ther; 2006 Feb; 6(1):1-15. PubMed ID: 16475942
[TBL] [Abstract][Full Text] [Related]
12. Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy.
Grisendi G; Bussolari R; Cafarelli L; Petak I; Rasini V; Veronesi E; De Santis G; Spano C; Tagliazzucchi M; Barti-Juhasz H; Scarabelli L; Bambi F; Frassoldati A; Rossi G; Casali C; Morandi U; Horwitz EM; Paolucci P; Conte P; Dominici M
Cancer Res; 2010 May; 70(9):3718-29. PubMed ID: 20388793
[TBL] [Abstract][Full Text] [Related]
13. [Cloning and recombinant expression of human soluble TRAIL in Pichia pastoris].
Li Y; Wan L; Yang H; Liu S; Cai H; Lu X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Dec; 27(6):1307-11, 1326. PubMed ID: 21374984
[TBL] [Abstract][Full Text] [Related]
14. Production of an infectious Herpesvirus saimiri-based episomally maintained amplicon system.
Macnab S; White R; Hiscox J; Whitehouse A
J Biotechnol; 2008 Apr; 134(3-4):287-96. PubMed ID: 18328588
[TBL] [Abstract][Full Text] [Related]
15. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector.
Rubinchik S; Yu H; Woraratanadharm J; Voelkel-Johnson C; Norris JS; Dong JY
Cancer Gene Ther; 2003 Nov; 10(11):814-22. PubMed ID: 14605667
[TBL] [Abstract][Full Text] [Related]
16. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
Ye X; Lu Q; Zhao Y; Ren Z; Ren XW; Qiu QH; Tong Y; Liang M; Hu F; Chen HZ
Int J Mol Med; 2005 Dec; 16(6):1179-84. PubMed ID: 16273304
[TBL] [Abstract][Full Text] [Related]
17. Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
Wang Y; Huang F; Cai H; Zhong S; Liu X; Tan WS
J Gene Med; 2008 May; 10(5):518-26. PubMed ID: 18338833
[TBL] [Abstract][Full Text] [Related]
18. Cancer gene therapy using a novel secretable trimeric TRAIL.
Kim CY; Jeong M; Mushiake H; Kim BM; Kim WB; Ko JP; Kim MH; Kim M; Kim TH; Robbins PD; Billiar TR; Seol DW
Gene Ther; 2006 Feb; 13(4):330-8. PubMed ID: 16195699
[TBL] [Abstract][Full Text] [Related]
19. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
[TBL] [Abstract][Full Text] [Related]
20. Potential of herpesvirus saimiri-based vectors to reprogram a somatic Ewing's sarcoma family tumor cell line.
Brown HF; Unger C; Whitehouse A
J Virol; 2013 Jun; 87(12):7127-39. PubMed ID: 23596304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
